Spruce Biosciences, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Spruce Biosciences, Inc. (SPRB) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -2.90% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2026-03-09
- Spruce Biosciences, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was -2.90%.
- Spruce Biosciences, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was -5.30%.
- Spruce Biosciences, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was -0.50%.
- Spruce Biosciences, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2021 was -0.40%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | -2.90% 10-K · filed 2026-03-09 | |
| 2023-12-31 | -5.30% 10-K · filed 2025-04-15 | |
| 2022-12-31 | -0.50% 10-K · filed 2024-03-18 | |
| 2021-12-31 | -0.40% 10-K · filed 2023-03-16 | -0.38% 10-K · filed 2022-03-14 |
| 2020-12-31 | -0.09% 10-K · filed 2022-03-14 | |
| 2019-12-31 | 0.14% 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |